Aspire Biopharma
ASBP
Aspire Biopharma (ASBP) news
Recent news
Aspire Biopharma - to pay $30 mln plus $800,000 deferred revenue as purchase price - SEC filing
AInvest Wire · Jun 12, 2026Aspire Biopharma - to buy all equity interests in specified Firefish Topco subsidiaries - SEC filing
AInvest Wire · Jun 12, 2026Aspire Biopharma - enters purchase agreement with Firefish Topco on June 10, 2026 - SEC filing
Aspire Biopharma Holdings, Inc. (NASDAQ: ASBP) has entered into a definitive purchase agreement with Firefish Topco, LLC on June 10, 2026, to acquire 100% of the Driver Controls Systems (DCS) business unit, following a non-binding letter of intent disclosed in an April 15, 2026, SEC filing. The…
AInvest Wire · Jun 12, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.